Fujian Wanchen Biotechnology Co Ltd
SZSE:300972

Watchlist Manager
Fujian Wanchen Biotechnology Co Ltd Logo
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
Watchlist
Price: 211 CNY 1.44% Market Closed
Market Cap: ¥40.4B

Fujian Wanchen Biotechnology Co Ltd
Other Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Fujian Wanchen Biotechnology Co Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Fujian Wanchen Biotechnology Co Ltd
SZSE:300972
Other Current Assets
¥1.8B
CAGR 3-Years
242%
CAGR 5-Years
211%
CAGR 10-Years
N/A
Inner Mongolia Yili Industrial Group Co Ltd
SSE:600887
Other Current Assets
¥41.2B
CAGR 3-Years
72%
CAGR 5-Years
39%
CAGR 10-Years
44%
Foshan Haitian Flavouring and Food Co Ltd
SSE:603288
Other Current Assets
¥292.1m
CAGR 3-Years
70%
CAGR 5-Years
77%
CAGR 10-Years
45%
Yihai Kerry Arawana Holdings Co Ltd
SZSE:300999
Other Current Assets
¥13B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Muyuan Foods Co Ltd
SZSE:002714
Other Current Assets
¥2.7B
CAGR 3-Years
5%
CAGR 5-Years
-2%
CAGR 10-Years
19%
Wens Foodstuff Group Co Ltd
SZSE:300498
Other Current Assets
¥939.4m
CAGR 3-Years
-36%
CAGR 5-Years
-14%
CAGR 10-Years
-16%
No Stocks Found

Fujian Wanchen Biotechnology Co Ltd
Glance View

Market Cap
40.4B CNY
Industry
Food Products

In the coastal province of Fujian, a vibrant ecosystem of innovation thrives with Fujian Wanchen Biotechnology Co. Ltd. at the helm. The company, a beacon of the region's progressive biotech sector, has carved its niche through the development and commercialization of advanced agricultural and health products. At its core, Fujian Wanchen leverages cutting-edge biotechnological research to produce high-quality bio-fertilizers and crop enhancers, addressing the pressing needs of sustainable agriculture. By deploying these organic solutions, it not only fosters healthier crop yields for farmers but also ensures environmental safety, aligning perfectly with global ecological standards. The company stands out in its ability to seamlessly meld technology with traditional agriculture, ensuring that age-old practices are reinforced with modern, efficient solutions. From the fertile fields of Fujian to the bustling trade networks of China and beyond, Fujian Wanchen’s influence extends across significant markets, underpinning its robust revenue streams. The firm earns its profits through a strategic combination of product sales, research partnerships, and licensing of its proprietary technologies. By forging strong alliances with both local and international agricultural entities, it has created a sustainable business model that thrives on innovation and collaboration. The company's expertise in biotechnological applications not only meets the agricultural demand but also ventures into nutraceuticals, offering health supplements that capitalize on the rich biodiversity of the region. This dual focus on agriculture and health positions Fujian Wanchen as a leader in harnessing nature’s potential for both nourishment and prosperity, carving a pathway to a more sustainable future.

Intrinsic Value
349.39 CNY
Undervaluation 40%
Intrinsic Value
Price ¥211

See Also

What is Fujian Wanchen Biotechnology Co Ltd's Other Current Assets?
Other Current Assets
1.8B CNY

Based on the financial report for Dec 31, 2025, Fujian Wanchen Biotechnology Co Ltd's Other Current Assets amounts to 1.8B CNY.

What is Fujian Wanchen Biotechnology Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
211%

Over the last year, the Other Current Assets growth was 52%. The average annual Other Current Assets growth rates for Fujian Wanchen Biotechnology Co Ltd have been 242% over the past three years , 211% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett